Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients

Clinical trial NCT06531369 · UNKNOWN

Trial details

NCT number: NCT06531369
Sponsor: Qianfoshan Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Flumazenil to Antagonize Remimazolam Remimazolam Renal Transplantation

Start date: 2024-07-01
Primary completion: 2025-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.